As an open access journal, Childhood Kidney Diseases (ChiKD) will follow the Principles of Transparency and Best Practice in Scholarly Publishing (https://doaj.org/bestpractice) developed by Committee on Publication Ethics (COPE), the Directory of Open Access Journals (DOAJ), the Open Access Scholarly Publishers Association (OASPA), and the World Association of Medical Editors (WAME).

1. Website

The URL of official journal web site is https://chikd.org.
pISSN: 2384-0242; eISSN: 2384-0250

2. Name of journal

ChiKD is the official publication of the Korean Society of Pediatric Nephrology. Its formal abbreviated title is “Child Kidney Dis.”

3. Peer review process

ChiKD reviews all received materials. All papers are evaluated by a double-blind, peer-review process. Manuscripts are sent to the two (or more) most relevant investigators, who review the content. The acceptance criteria for all papers are based on the quality and originality of the research and its clinical and scientific significance. An initial decision will normally be made within 2 weeks after the reviewers agree to review a manuscript, and the reviewers’ comments will then be sent to the corresponding authors. Revised manuscripts must be submitted online by the corresponding author. Failure to resubmit the revised manuscript within 4 weeks of the editorial decision is regarded as a withdrawal. The editorial office should be notified if additional time is needed or if an author chooses not to submit a revision. The editorial committee makes decisions concerning editing, revision, and acceptance or rejection, and editing may include shortening an article, reducing the number of illustrations or tables, or changing the paper's format or the order of the manuscript. The editor selects referees, and the results of reviews will be classified as follows:

• Accepted: The manuscript will be forwarded to the publisher without further corrections.
• Minor revision: The author should address the comments from the reviewers, which will be confirmed by the reviewers.
• Major revision: The author should address the comments from the reviewers and make the appropriate corrections for review by the reviewers.
• Rejection: When one out of the two (or more) reviewers rejects the manuscript, the final decision is made by the editorial committee.

4. Ownership and management

This journal is owned by the publisher, Korean Society of Pediatric Nephrology (http://www.kspn.org).
The full names and affiliations of the members of the journal management team are displayed on the About (Managing team) tab of the journal homepage.

5. Governing body

The governing body is the journal's editorial board (http://www.chikd.org/about/editorial.php).

6. Editorial team and contact information

• Editorial Team: The full names and affiliations of the journal’s editors are displayed on the About (Editorial board) tab of the journal homepage. All the members are responsible to improve the scientific quality of the journal and to implement editorial policy approved by the editorial board.
• Contact Information: The contact information for the Editor-in-Chief and the Editorial Office is on the About (Contact us) tab.

7. Copyright and licensing

• Copyright policy: All published papers become the permanent property of the Korean Society of Pediatric Nephrology. Copyrights of all published materials are owned by the Korean Society of Pediatric Nephrology and permission must be obtained for any commercial use of materials. Every author must sign the Transfer of Copyright Agreement forms.
• Licensing information: This is an open access journal distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

8. Article processing charges

There are no author submission fees or other publication-related charges. All cost for the publication process is supported by the publisher. ChiKD is a so-called platinum open access journal which does not charge author fees.

9. Process for identification of and dealing with allegations of research misconduct

When the journal faces suspected cases of research and publication misconduct such as redundant (duplicate) publication, plagiarism, fraudulent or fabricated data, changes in authorship, an undisclosed conflict of interest, ethical problems with a submitted manuscript, a reviewer who has appropriated an author’s idea or data, complaints against editors, and so on, the resolution process will follow the flowchart provided by the Committee on Publication Ethics (http://publicationethics.org/resources/flowcharts). The discussion and decision on the suspected cases are carried out by the Research Ethics Committee of the ChiKD. We will not hesitate to publish errata, corrigenda, clarifications, retractions, and apologies when needed.

10. Publication Ethics

ChiKD follows the Guideline on Good Publication of COPE (https://publicationethics.org), Recommendations of International Committee of Medical Journal Editors (http://www.icmje.org/recommendations), and Good Publication Practice Guidelines for Medical Journals of Korean Association of Medical Journal Editors (http://kamje.or.kr). Our publication ethics are displayed on the Editorial policy (Publication ethics) tab of journal homepage.

11. Publishing schedule

ChiKD is published 2 times (June 30, December 31) a year. The e-pub versions of all articles have been promptly seen after the acceptance in the journal homepage.

12. Access

ChiKD is an open access journal. A free full-text service both in the XML and PDF formats is available immediately upon publication without embargo period.

13. Archiving

Full text of ChiKD is accessible without barrier from Korea Citation Index (https://www.kci.go.kr/kciportal/main.kci) or National Library of Korea (http://www.nl.go.kr).

14. Revenue sources

Revenue sources of this journal are from the support of publisher (the Korean Society of Pediatric Nephrology), Korea Government’s support, and advertising rates.

15. Advertising

We accept advertising and sponsorship for its printed journal according to the following principles:

• Advertising is separate from content. Advertisers and sponsors have no advance knowledge of our editorial contents, nor do the editors have advance knowledge of advertisers. Content is never altered, added, or deleted to accommodate advertising. Advertisers and sponsors have no input regarding any of our editorial decisions or advertising policies.
• We reserve the right to decline or cancel any advertisement at any time.
• Advertisements for pharmaceutical products must conform to all regulations and policies of the Ministry of Food and Drug Safety, Republic of Korea in every respect.

16. Direct marketing

Journal propagation has been done through the journal web site and distribution of an introduction pamphlet. Invitations to submit a manuscript are usually focused on the presenters at conferences, seminars, or workshops if the topic is related to the journal's aims and scope.